Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Sales | 3,394 | 67 | 20 | 20 | 20 |
| Cost of Goods | 890 | N/A | N/A | N/A | N/A |
| Gross Profit | 2,504 | 18 | 20 | 20 | 20 |
| Operating Expenses | 39,296 | 38,534 | 49,338 | 25,898 | 23,623 |
| Operating Income | -35,902 | -38,467 | -49,318 | -25,878 | -23,603 |
| Interest Expense | 9,766 | 96 | 2,127 | 2,098 | 6,226 |
| Other Income | 7,472 | 960 | 2,938 | 2,014 | 3,715 |
| Pre-tax Income | -38,196 | -37,603 | -48,507 | -25,962 | -26,114 |
| Net Income Continuous | -38,196 | -37,639 | -48,471 | -25,962 | -26,114 |
| Minority Interests | -32 | N/A | N/A | N/A | N/A |
| Net Income | $-38,164 | $-37,561 | $-48,471 | $-25,962 | $-26,114 |
| EPS Basic Total Ops | -2,303.54 | -2,321.54 | -3,272.35 | -1,949.61 | -2,279.54 |
| EPS Basic Continuous Ops | -1,612.00 | -2,228.40 | -3,016.26 | -1,823.11 | -2,083.81 |
| EPS Diluted Total Ops | -2,303.54 | -2,321.54 | -3,272.35 | -1,949.61 | -2,279.54 |
| EPS Diluted Continuous Ops | -1,612.00 | -2,228.40 | -3,016.26 | -1,823.11 | -2,083.81 |
| EBITDA(a) | $-34,333 | $-37,318 | $-48,205 | $-24,580 | $-22,208 |